about
sameAs
Peroxisomes are signaling platforms for antiviral innate immunityPerforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells.Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.Visualization of Double-Stranded RNA in Cells Supporting Hepatitis C Virus RNA ReplicationInitiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network: ROLE OF THE VIRAL NUCLEOCAPSID PROTEINSimilar uptake but different trafficking and escape routes of reovirus virions and infectious subvirion particles imaged in polarized Madin-Darby canine kidney cells.Diverse intracellular pathogens activate type III interferon expression from peroxisomesThe first five seconds in the life of a clathrin-coated pit.Dynamics of intracellular clathrin/AP1- and clathrin/AP3-containing carriers.Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner.Lipid metabolism and HCV infectionHost cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments.Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication.Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosisGenome packaging of reovirus is mediated by the scaffolding property of the microtubule network.Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking.Human cytomegalovirus UL44 concentrates at the periphery of replication compartments, the site of viral DNA synthesis.Bin1 directly remodels actin dynamics through its BAR domain.Reovirus inhibits interferon production by sequestering IRF3 into viral factories.Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus.Expression of the alternative reading frame protein of Hepatitis C virus induces cytokines involved in hepatic injuries.Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.Reovirus intermediate subviral particles constitute a strategy to infect intestinal epithelial cells by exploiting TGF-β dependent pro-survival signaling.HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly SitesHepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA.Structural determinants that target the hepatitis C virus core protein to lipid droplets.Clathrin-adaptor ratio and membrane tension regulate the flat-to-curved transition of the clathrin coat during endocytosis.A PRDX1-p38α heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas.Rubella Virus Strain-Associated Differences in the Induction of Oxidative Stress Are Independent of Their Interferon ActivationDifferential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundanceReversible Fusion Proteins as a Tool to Enhance Uptake of Virus-Functionalized LbL MicrocarriersNovel Chimeric Gene Therapy Vectors Based on Adeno-Associated Virus and Four Different Mammalian BocavirusesDifferential Regulation of Type I and Type III Interferon SignalingAssaying the Contribution of Membrane Tension to Clathrin-Mediated EndocytosisAsymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cellsNovel Toscana Virus Reverse Genetics System Establishes NSs as an Antagonist of Type I Interferon ResponsesHypoxic Environment Promotes Barrier Formation in Human Intestinal Epithelial Cells through Regulation of MicroRNA 320a ExpressionTeratogenic Rubella Virus Alters the Endodermal Differentiation Capacity of Human Induced Pluripotent Stem Cells
P50
Q24310723-EE50E09C-7D64-49A7-8323-74B1E77A9C18Q24630734-22C05594-E5B9-48CB-9767-439F14A556E8Q24630734-F0B5F71D-2639-45FF-8D00-7606BBC2C81EQ27470776-2099ECBC-8D0F-41C2-BDA4-89C30D985098Q27485448-F5EF54CE-1618-44C3-A5B0-0C0D8344A9A4Q27488371-EF611E0C-4F76-4BEF-9614-03D17AAEB4F3Q30538733-5E3E8806-9DFC-4326-8817-92B163BDACBEQ33933986-D28F309D-D675-4156-9820-532F5EAEA723Q34292187-5FBCC64D-2E9F-44DF-AEDA-75082FE73E28Q34308501-2C75F133-D81F-474B-B790-FC0FBC6F1095Q34779622-51FEA022-AEC5-4810-AAB6-E52370A33889Q35275932-EF58981C-2CAB-4152-BA64-31EC0C0C18F4Q35759789-5F89D7DD-C76F-45C1-97C1-D1E2618C73ACQ38348043-96AAE15E-DDDD-4F43-8D4A-6F0E7EF843AAQ38515936-E7132F6C-7C58-4AD4-BFA4-40A7C625D9ADQ38696576-73EABE1E-2434-48E8-BFD0-862A31134699Q39104403-E784F394-7C2E-4ED8-ACEF-8E49F06C05FFQ39430547-04E37E51-1B52-47AC-916F-C03867DDE8EAQ40046724-5578386D-D203-4703-8DF1-027B41730B73Q40052207-426A079F-0743-4E20-A246-3363FCA64789Q40109003-C73ACBE9-3E3C-4D27-91B4-85D58D3D0614Q40156286-A55D6BED-D410-41AC-964E-EF4FE7F554D3Q40209553-7D8CAD3B-FC22-4D19-A5C5-8E46303AA05FQ40373925-F805405E-A586-4A37-AC42-97D8C4A8D00AQ40639992-33C91F8F-6ACF-4B27-A68A-DB756EDA95A3Q40677862-AD8A2ACE-4F5B-4A21-BE0A-50D6D46BDB46Q42991255-AE159DCE-6DDF-4777-9705-DDCA31178645Q43000172-373C5D70-3CBD-489E-B36E-C889E45325C0Q52651254-8A0381C6-FCB1-42F1-9456-AD7E22739866Q52723888-FFFAAB35-7709-4209-B8F9-781DBD91D5A0Q57042546-FD2A60EF-D564-4E37-9F49-A312C9386A56Q59349778-B1D39621-7A23-4C95-A538-79864952E8FFQ59357756-153C422A-71D3-4BEF-A4EF-60545BBE77ACQ61813605-7B38E173-97D1-447B-BE47-52AB857EE51EQ64065850-55085020-482B-4163-B3B5-BC0DF67CCB20Q91056655-4C67C51E-1AE5-4BB3-9CFC-2A8D8ED97A37Q91106719-7AE18838-20E7-4737-881F-DA5F85BED7BFQ91669878-BA54B91A-398C-4425-9B86-830DF3CB8E54Q91803027-2AFD1E9A-9893-4366-8856-28E6063F5B52Q92571185-3B52773F-E054-4F1C-A14C-1E99E55F9074
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Steeve Boulant
@ast
Steeve Boulant
@en
Steeve Boulant
@es
Steeve Boulant
@nl
Steeve Boulant
@sl
type
label
Steeve Boulant
@ast
Steeve Boulant
@en
Steeve Boulant
@es
Steeve Boulant
@nl
Steeve Boulant
@sl
prefLabel
Steeve Boulant
@ast
Steeve Boulant
@en
Steeve Boulant
@es
Steeve Boulant
@nl
Steeve Boulant
@sl
P106
P1153
8070197900
P21
P214
9537149368865185980003
P31
P496
0000-0001-8614-4993
P7859
viaf-9537149368865185980003